latanoprost ocular implant (PA5108) / PolyActiva 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  latanoprost ocular implant (PA5108) / PolyActiva
    Enrollment closed, Trial completion date, Trial primary completion date:  Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma (clinicaltrials.gov) -  Apr 12, 2024   
    P1,  N=37, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Aug 2023 --> Feb 2025 | Trial primary completion date: Aug 2023 --> Sep 2024
  • ||||||||||  latanoprost ocular implant (PA5108) / PolyActiva
    Enrollment change, Trial completion date, Trial primary completion date:  Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma (clinicaltrials.gov) -  Dec 22, 2021   
    P1,  N=40, Recruiting, 
    Recruiting --> Active, not recruiting | Trial completion date: Aug 2023 --> Feb 2025 | Trial primary completion date: Aug 2023 --> Sep 2024 N=30 --> 40 | Trial completion date: Dec 2021 --> Aug 2023 | Trial primary completion date: Nov 2021 --> Aug 2023
  • ||||||||||  latanoprost ocular implant (PA5108) / PolyActiva
    Enrollment closed, Trial completion date, Trial primary completion date:  Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma (clinicaltrials.gov) -  Mar 6, 2020   
    P1,  N=7, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Sep 2019 --> Sep 2020 | Trial primary completion date: May 2019 --> May 2020